SCHEMBL14723602

SCHEMBL14723602

N[C@@H]1CN(Cc2ccccc2)CC1c1ccccc1F

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 3/20 0.61
KDM1A O60341 3/20 0.51
KDM1B Q8NB78 1/20 0.51
DRD2 P14416 2/20 0.48
DRD3 P35462 2/20 0.48
FUCA1 P04066 2/20 0.44
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
ROCK2 O75116 1/20 0.42
S1PR1 P21453 1/20 0.42
S1PR5 Q9H228 1/20 0.42
HTR2C P28335 1/20 0.42
HTR2B P41595 1/20 0.42
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
RORC P51449 1/20 0.41
SIGMAR1 Q99720 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14730265 1.00 DPP4 (0.61) DPP4KDM1AKDM1BDRD2DRD3
SCHEMBL14723600 1.00 DPP4 (0.61) DPP4KDM1AKDM1BDRD2DRD3
SCHEMBL470598 0.90 DPP4 (0.61) DPP4KDM1AKDM1BDRD2DRD3
SCHEMBL147328 0.86 DPP4 (0.63) DPP4KDM1ADRD2DRD3FUCA1
SCHEMBL147330 0.86 DPP4 (0.63) DPP4KDM1ADRD2DRD3FUCA1
SCHEMBL1725958 0.86 DPP4 (0.63) DPP4KDM1ADRD2DRD3FUCA1
SCHEMBL147329 0.86 DPP4 (0.63) DPP4KDM1ADRD2DRD3FUCA1
SCHEMBL14730218 0.86 DPP4 (0.63) DPP4KDM1AKDM1BDRD2DRD3
SCHEMBL6125565 0.86 DPP4 (0.63) DPP4KDM1AKDM1BDRD2DRD3
SCHEMBL149731 0.86 DPP4 (0.64) DPP4DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013026587-A1 1,4 DISUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2013-02-28 WO disclosed